127 results
8-K
EX-99.1
BCPC
Balchem Corp.
3 May 24
Balchem Corporation Reports First Quarter 2024 Financial Results
7:07am
the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
8-K
EX-99.1
BCPC
Balchem Corp.
16 Feb 24
Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
7:14am
Statements
This release contains forward-looking statements, within the meaning of the meaning of the Private Securities Litigation Reform Act of 1995
8-K
EX-99.1
cq5g1ihecz535inq7
27 Oct 23
Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04
7:11am
8-K
EX-99.1
s2g 5fm3n5
28 Jul 23
Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06
7:07am
8-K
EX-10.1
mrs7r13f1pwgt
26 Jun 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
r17e87xp5kot
28 Apr 23
Results of Operations and Financial Condition
7:06am
8-K
EX-4.1
rd6mwwbt
1 Aug 22
Entry into a Material Definitive Agreement
6:04am
8-K
EX-2.1
x8zohhkfo pgc6u8fcy
15 Jun 22
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS About Balchem Corporation
1:59pm